Banchereau, Romain
Leng, Ning
Zill, Oliver http://orcid.org/0000-0002-4329-2790
Sokol, Ethan
Liu, Gengbo http://orcid.org/0000-0002-5103-7191
Pavlick, Dean
Maund, Sophia
Liu, Li-Fen
Kadel, Edward III http://orcid.org/0000-0003-3030-6628
Baldwin, Nicole http://orcid.org/0000-0002-4196-3554
Jhunjhunwala, Suchit
Nickles, Dorothee
Assaf, Zoe June
Bower, Daniel
Patil, Namrata
McCleland, Mark
Shames, David
Molinero, Luciana
Huseni, Mahrukh http://orcid.org/0000-0001-8166-3401
Sanjabi, Shomyseh http://orcid.org/0000-0002-3097-9665
Cummings, Craig
Mellman, Ira http://orcid.org/0000-0002-6132-7299
Mariathasan, Sanjeev http://orcid.org/0000-0001-5034-773X
Hegde, Priti
Powles, Thomas http://orcid.org/0000-0001-7760-4724
Funding for this research was provided by:
Roche
Article History
Received: 3 September 2020
Accepted: 13 May 2021
First Online: 25 June 2021
Competing interests
: R.B., N.L., O.Z., G.L., S.M., L.-F.L., E.K., S.J., D.N., Z.J.A., D.B., N.P., M.M., D.S., L.M., M.H., S.S., C.C., I.M., and S.M. are Roche employees. E.S., D.P., and P.H. are Foundation Medicine employees. N.B. declares no competing interests. T.P. is a consultant for AstraZeneca, Bristol Myers Squibb, Exelixis, Incyte, Ipsen, Merck, MSD, Novartis, Pfizer, Seattle Genetics, Merck Serono, Astellas, Johnson & Johnson, Eisai, and Roche.